Evidence map›Paper›PMID 30254736›Full record

ArticleF1000Research2018

Common ELIXIR Service for Researcher Authentication and Authorisation.

Mikael Linden, Michal Prochazka, Ilkka Lappalainen, Dominik Bucik, Pavel Vyskocil, Martin Kuba, Sami Silén, Peter Belmann, Alexander Sczyrba, Steven Newhouse and 2 more

Abstract read
In one paragraph

Article in F1000Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. MolViewStories: Interactive molecular storytelling.Protein science : a publication of the Protein Society · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The European Genome-phenome Archive in 2021.Nucleic acids research · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. From ArrayExpress to BioStudies.Nucleic acids research · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mikael LindenCSC - IT Center for Science, Espoo, Finland.ORCID 0000-0002-3634-3756
Michal ProchazkaMasaryk University, Brno, Czech Republic.
Ilkka LappalainenCSC - IT Center for Science, Espoo, Finland.
Dominik BucikMasaryk University, Brno, Czech Republic.
Pavel VyskocilMasaryk University, Brno, Czech Republic.
Martin KubaMasaryk University, Brno, Czech Republic.ORCID 0000-0002-0305-7446
Sami SilénCSC - IT Center for Science, Espoo, Finland.
Peter BelmannBielefeld University, Bielefeld, Germany.
Alexander SczyrbaBielefeld University, Bielefeld, Germany.
Steven NewhouseEMBL-EBI, Hinxton, UK.
Ludek MatyskaMasaryk University, Brno, Czech Republic.
Tommi NyrönenCSC - IT Center for Science, Espoo, Finland.ORCID 0000-0002-5569-5183

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A common Authentication and Authorisation Infrastructure (AAI) that would allow single sign-on to services has been identified as a key enabler for European bioinformatics. ELIXIR AAI is an ELIXIR service portfolio for authenticating researchers to ELIXIR services and assisting these services on user privileges during research usage. It relieves the scientific service providers from managing the user identities and authorisation themselves, enables the researcher to have a single set of credentials to all ELIXIR services and supports meeting the requirements imposed by the data protection laws. ELIXIR AAI was launched in late 2016 and is part of the ELIXIR Compute platform portfolio. By the end of 2017 the number of users reached 1000, while the number of relying scientific services was 36. This paper presents the requirements and design of the ELIXIR AAI and the policies related to its use, and how it can be used for serving some example services, such as document management, social media, data discovery, human data access, cloud compute and training services.

Indexed as

Computer SecurityDatabase Management SystemsSoftwareBiomedical ResearchComputational BiologyHumansResearch PersonnelUser-Computer Interfaceauthenticationauthorisationdata accessGA4GHGDPRIAM

Identifiers

PMID30254736
PMCPMC6124379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.